Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study
- PMID: 29784617
- PMCID: PMC6109597
- DOI: 10.1053/j.ajkd.2018.02.363
Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study
Erratum in
-
Erratum Regarding "Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study" (Am J Kidney Dis. 2018;72[3]:390-399).Am J Kidney Dis. 2020 May;75(5):817. doi: 10.1053/j.ajkd.2020.02.435. Epub 2020 Mar 16. Am J Kidney Dis. 2020. PMID: 32192785 Free PMC article. No abstract available.
Abstract
Rationale & objective: Abnormal cardiac structure and function are common in chronic kidney disease (CKD) and end-stage renal disease (ESRD) and linked with mortality and heart failure. We examined changes in echocardiographic measures during the transition from CKD to ESRD and their associations with post-ESRD mortality.
Study design: Prospective study.
Setting & participants: We studied 417 participants with CKD in the Chronic Renal Insufficiency Cohort (CRIC) who had research echocardiograms during CKD and ESRD.
Predictor: We measured change in left ventricular mass index, left ventricular ejection fraction (LVEF), diastolic relaxation (normal, mildly abnormal, and moderately/severely abnormal), left ventricular end-systolic (LVESV), end-diastolic (LVEDV) volume, and left atrial volume from CKD to ESRD.
Outcomes: All-cause mortality after dialysis therapy initiation.
Analytical approach: Cox proportional hazard models were used to test the association of change in each echocardiographic measure with postdialysis mortality.
Results: Over a mean of 2.9 years between pre- and postdialysis echocardiograms, there was worsening of mean LVEF (52.5% to 48.6%; P<0.001) and LVESV (18.6 to 20.2mL/m2.7; P<0.001). During this time, there was improvement in left ventricular mass index (60.4 to 58.4g/m2.7; P=0.005) and diastolic relaxation (11.11% to 4.94% with moderately/severely abnormal; P=0.02). Changes in left atrial volume (4.09 to 4.15mL/m2; P=0.08) or LVEDV (38.6 to 38.4mL/m2.7; P=0.8) were not significant. Worsening from CKD to ESRD of LVEF (adjusted HR for every 1% decline in LVEF, 1.03; 95% CI, 1.00-1.06) and LVESV (adjusted HR for every 1mL/m2.7 increase, 1.04; 95% CI, 1.02-1.07) were independently associated with greater risk for postdialysis mortality.
Limitations: Some missing or technically inadequate echocardiograms.
Conclusions: In a longitudinal study of patients with CKD who subsequently initiated dialysis therapy, LVEF and LVESV worsened and were significantly associated with greater risk for postdialysis mortality. There may be opportunities for intervention during this transition period to improve outcomes.
Keywords: CKD to ESRD transition; Kidney; all-cause mortality; cardiac disease; cardiovascular disease (CVD); dialysis; dialysis initiation; diastolic relaxation; echocardiogram; end-stage renal disease (ESRD); heart failure; left atrial volume; left ventricular ejection fraction (LVEF); left ventricular end-diastolic volume (LVEDV); left ventricular end-systolic volume (LVESV); left ventricular mass index (LVMI); subclinical CVD.
Copyright © 2018 National Kidney Foundation, Inc. All rights reserved.
References
-
- Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339(12):799–805. - PubMed
-
- Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305. - PubMed
-
- Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996;49(5):1379–1385. - PubMed
-
- Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11(7):1277–1285. - PubMed
Publication types
MeSH terms
Grants and funding
- UL1 TR002548/TR/NCATS NIH HHS/United States
- K01 DK092353/DK/NIDDK NIH HHS/United States
- U01 DK060963/DK/NIDDK NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- K23 DK088865/DK/NIDDK NIH HHS/United States
- U01 DK060990/DK/NIDDK NIH HHS/United States
- UL1 TR002240/TR/NCATS NIH HHS/United States
- K24 DK092291/DK/NIDDK NIH HHS/United States
- UL1 RR029879/RR/NCRR NIH HHS/United States
- U01 DK061028/DK/NIDDK NIH HHS/United States
- UL1 TR000433/TR/NCATS NIH HHS/United States
- U01 DK060984/DK/NIDDK NIH HHS/United States
- U01 DK061021/DK/NIDDK NIH HHS/United States
- U24 DK060990/DK/NIDDK NIH HHS/United States
- R01 DK070939/DK/NIDDK NIH HHS/United States
- P30 GM103337/GM/NIGMS NIH HHS/United States
- U01 DK060980/DK/NIDDK NIH HHS/United States
- U01 DK061022/DK/NIDDK NIH HHS/United States
- R01 DK103612/DK/NIDDK NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- P20 GM109036/GM/NIGMS NIH HHS/United States
- U01 DK060902/DK/NIDDK NIH HHS/United States
- UL1 TR002003/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
